Cover Image
市場調查報告書

血漿的全球市場:產業分析與展望

Global Blood Plasma Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 233439
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
血漿的全球市場:產業分析與展望 Global Blood Plasma Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年04月26日 內容資訊: 英文 83 Pages
簡介

本報告提供全球血漿市場相關調查分析,以主要地區市場為焦點,提供主要趨勢和發展,課題,競爭情形,主要企業簡介等系統性資訊。

第1章 市場概要

  • 血漿
  • 血漿的衍生物
  • 血漿的功能
  • 血漿的收集、開採

第2章 血漿的全球市場分析

  • 血漿市場預測:各金額
  • 血漿分配容量的預測
  • 血漿市場:各地區
  • 血漿市場:各種類
  • 免疫球蛋白(Ig)的全球市場
    • 免疫球蛋白市場預測:各金額
    • 免疫球蛋白市場預測:各數量
    • 免疫球蛋白市場規模:各地區
    • 免疫球蛋白市場:各類型
    • 免疫球蛋白治療人口:各症狀
  • 白蛋白的全球市場
    • 白蛋白市場預測:各金額
    • 白蛋白市場預測:各數量
    • 白蛋白市場規模:各地區
  • 血液凝固第八凝血因子(Factor VIII)
    • 血液凝固第八凝血因子市場預測:各金額
    • 血液凝固第八凝血因子市場預測:各數量
    • 血液凝固第八凝血因子市場:各類型

第3章 地區分析

  • 美國
    • 血漿市場:各種類
    • 免疫球蛋白市場預測:各金額
    • 免疫球蛋白市場預測:各數量
    • 免疫球蛋白市場規模:各種類
    • 免疫球蛋白市場:各特性
    • 白蛋白市場預測:各金額
  • 中國
    • 血漿市場預測:各金額
    • 血漿市場:各種類
    • 白蛋白市場預測:各金額
    • 免疫球蛋白市場預測:各金額
    • 血液凝固第八凝血因子市場預測:各金額

第4章 市場動態

  • 市場趨勢
  • 成長推動因素
  • 市場課題

第5章 競爭環境

  • 血漿的全球市場
    • 血漿的市場佔有率
    • 免疫球蛋白的市場佔有率
    • 白蛋白的市場佔有率
    • 血漿來源的血液凝固第八凝血因子的市場佔有率
    • α1-抗胰蛋白酶(A1AT)的市場佔有率
    • 血漿中心:各企業

第6章 企業簡介

  • Shire Plc.
  • CSL Limited
  • Grifols, S.A.
  • Octapharma, Inc.

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Plasma is obtained from blood after separation from red blood cells, white blood cells and platelets. The major components of blood plasma include proteins, amino acids, and other essential nutrients. Among these, proteins form the most important part of plasma and constitutes albumin, immunoglobulin, factor VIII, factor IX, alpha1 and many more. Plasma proteins are extracted from blood and used for many therapeutic indications.

Blood plasma is important because they fight off foreign substances that invade the body and transport nutrients and water. Plasma and recovered plasma are used to produce therapies that treat people with rare, chronic diseases and disorders such as primary immunodeficiency, hemophilia and genetic lung disease, as well as in the treatment of trauma, burns and shock. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collections over the time.

Growth factors of the global blood plasma market include increased diagnosis rate, rise in plasma collections and robust growth in emerging economies. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, lengthy approval process and high R&D costs.

The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc.

Table of Contents

1. Market Overview

  • 1.1. Blood Plasma
  • 1.2. Blood Plasma Derivatives
  • 1.3. Functions of Blood Plasma
  • 1.4. Plasma Collection

2. Global Market Analysis

  • 2.1. Global Blood Plasma Market Forecast by Value
  • 2.2. Global Blood Plasma Fractionation Capacity Forecast
  • 2.3. Global Blood Plasma Market by Region
  • 2.4. Global Blood Plasma Market by Segment
  • 2.5. Global Immunoglobulin Market
    • 2.5.1. Global Immunoglobulin Market Forecast by Value
    • 2.5.2. Global Immunoglobulin Market Forecast by Volume
    • 2.5.3. Global Immunoglobulin Market Volume by Region
    • 2.5.4. Global Immunoglobulin Market by Types
    • 2.5.5. Global Immunoglobulin Population by Indication
  • 2.6. Global Albumin Market
    • 2.6.1. Global Albumin Market Forecast by Value
    • 2.6.2. Global Albumin Market Forecast by Volume
    • 2.6.3. Global Albumin Market Volume by Region
  • 2.7. Global Factor VIII Market
    • 2.7.1. Global Factor VIII Market Forecast by Value
    • 2.7.2. Global Factor VIII Market Forecast by Volume
    • 2.7.3. Global Factor VIII Market by Type

3. Regional Analysis

  • 3.1. The US
    • 3.1.1. The US Blood Plasma Market by Segments
    • 3.1.2. The US Immunoglobulin Market Forecast by Value
    • 3.1.3. The US Immunoglobulin Market Forecast by Volume
    • 3.1.4. The US Immunoglobulin Market Volume by Segment
    • 3.1.5. The US Immunoglobulin Market by Specialty
    • 3.1.6. The US Albumin Market Forecast by Volume
  • 3.2. China
    • 3.2.1. China's Blood Plasma Market Forecast by Value
    • 3.2.2. China's Blood Plasma Market by Segments
    • 3.2.3. China's Albumin Market Forecast by Value
    • 3.2.4. China's Immunoglobulin Market Forecast by Value
    • 3.2.5. China's Factor VIII Market Forecast by Value

4. Market Dynamics

  • 4.1. Trends & Developments
    • 4.1.1. Increasing Fractionation Capacity
    • 4.1.2. Growing AATD Market Potential
    • 4.1.3. Innovation in Therapeutics Via Existing and New Proteins
  • 4.2. Growth Drivers
    • 4.2.1. Increased Diagnosis of Disease Treated by Immunoglobulin
    • 4.2.2. Increasing Plasma Collection
    • 4.2.3. Growing Blood Plasma Market in Emerging Economies
    • 4.2.4. Popularity of Albumin in Asian Countries
    • 4.2.5. Increasing Healthcare Expenditure
    • 4.2.6. Escalating Ageing Population
  • 4.3. Challenges & Issues
    • 4.3.1. High Cost of Treatment
    • 4.3.2. Unclear & Lengthy Process to Open Plasma Centre
    • 4.3.3. High R&D Costs

5. Competitive Landscape

  • 5.1. Global Market
    • 5.1.1. Global Blood Plasma Market Share
    • 5.1.2. Global Immunoglobulin Market Share
    • 5.1.3. Global Albumin Market Share
    • 5.1.4. Global Plasma-Derived Factor VIII Market Share
    • 5.1.5. Global Alpha1 Market Share
    • 5.1.6. Global Blood Plasma Centers by Major Players

6. Company Profiles

  • 6.1. Shire Plc.
    • 6.1.1. Business Overview
    • 6.1.2. Financial Overview
    • 6.1.3. Business Strategies
  • 6.2. CSL Limited
    • 6.2.1. Business Overview
    • 6.2.2. Financial Overview
    • 6.2.3. Business Strategies
  • 6.3. Grifols, S.A.
    • 6.3.1. Business Overview
    • 6.3.2. Financial Overview
    • 6.3.3. Business Strategies
  • 6.4. Octapharma, Inc.
    • 6.4.1. Business Overview
    • 6.4.2. Financial Overview
    • 6.4.3. Business Strategies

List of Charts

  • Components of Blood Plasma
  • Global Blood Plasma Market Forecast by Value (2016-2021)
  • Global Blood Plasma Fractionation Capacity Forecast (2016-2021)
  • Global Blood Plasma Market by Region (2016)
  • Global Blood Plasma Market by Segment (2016)
  • Global Immunoglobulin Market Forecast by Value (2016-2021)
  • Global Immunoglobulin Market Forecast by Volume (2016-2021)
  • Global Immunoglobulin Market Volume by Region (2016)
  • Global Immunoglobulin Market by Types (2016)
  • Global Immunoglobulin Population by Indication (2016)
  • Global Albumin Market Forecast by Value (2016-2021)
  • Global Albumin Market Forecast by Volume (2016-2021)
  • Global Albumin Market Volume by Region (2016)
  • Global Factor VIII Market Forecast by Value (2016-2021)
  • Global Factor VIII Market Forecast by Volume (2016-2021)
  • Global Factor VIII Market by Type (2016)
  • The US Blood Plasma Market by Segment (2016)
  • The US Immunoglobulin Market Forecast by Value (2016-2021)
  • The US Immunoglobulin Market Forecast by Volume (2016-2021)
  • The US Immunoglobulin Market Volume by Segment (2016)
  • The US Immunoglobulin Market by Specialty (2016)
  • The US Albumin Market Forecast by Volume (2016-2021)
  • China's Blood Plasma Market Forecast by Value (2016-2021)
  • China's Blood Plasma Market by Segments (2016)
  • China's Albumin Market Forecast by Value (2016-2021)
  • China's Immunoglobulin Market Forecast by Value (2016-2021)
  • China's Factor VIII Market Forecast by Value (2016-2021)
  • Global Alpha1 Patient Population (2016)
  • The US CIDP Market Opportunity (2016)
  • Plasma Collection in the US (2012-2016)
  • Albumin Consumption Per Capita by Country (2016)
  • Global Healthcare Expenditure (2012-2016)
  • Global Ageing Population of 60 Years or Older (2000-2030E)
  • Global Blood Plasma Market Share by Company (2016)
  • Global Immunoglobulin Market Share by Company (2016)
  • Global Albumin Market Share by Company (2016)
  • Global Plasma-Derived Factor VIII Market Share by Company (2016)
  • Global Alpha1 Market Share by Company (2016)
  • Global Blood Plasma Centers by Major Players (2016)
  • Shire Plc. Revenue Share by Franchise (2016)
  • Shire PLC's Revenue and Net Income (2012-2016)
  • CSL Limited's Revenue Share by Products (2016)
  • CSL Limited's Revenue and Net Profit (2012-2016)
  • Research & Development Investments of CSL Limited (2012-2016)
  • Grifols, S.A. Revenue Share by Business Segments (2016)
  • Grifols, S.A. Revenue and Gross Profit (2012-2016)
  • Octapharma, Inc. Revenue (2012-2016)
  • List of Tables
  • Blood Plasma Protein Breakup
  • Functions of Blood Plasma
  • Fractionation Capacity of Key Market Players (2013-2022E)
  • Therapeutic Products Under Development (2016)
  • Shire PLC's Major Product Approvals & Launches (2016)
  • Shire PLC's Major Product Pipeline (2016)
  • CSL Ltd.'s Major Product Development (2016)
Back to Top